Volume 22, No 5, May 2012
ISSN: 1001-0602
EISSN: 1748-7838 2018
impact factor 17.848*
(Clarivate Analytics, 2019)
Volume 22 Issue 5, May 2012: 786-788
RESEARCH HIGHLIGHTS
Insights into Chinese prostate cancer with RNA-seq
Anirban Sahu1, Matthew K Iyer1 and Arul M Chinnaiyan1,2,3,4,5
1Michigan Center for Translational Pathology, University of Michigan Medical School, 1400 E. Medical Center Dr, 5316 Cancer Center, Ann Arbor, MI 48109-0602, USA
2Department of Pathology, University of Michigan Medical School, 1400 E. Medical Center Dr, 5316 Cancer Center, Ann Arbor, MI 48109-0602, USA
3Department of Urology, University of Michigan Medical School, 1400 E. Medical Center Dr, 5316 Cancer Center, Ann Arbor, MI 48109-0602, USA
4Comprehensive Cancer Center, University of Michigan Medical School, 1400 E. Medical Center Dr, 5316 Cancer Center, Ann Arbor, MI 48109-0602, USA
5Howard Hughes Medical Institute, University of Michigan Medical School, 1400 E. Medical Center Dr, 5316 Cancer Center, Ann Arbor, MI 48109-0602, USA
Correspondence: Arul M Chinnaiyan,(arul@umich.edu)
The prevalence of certain driver mutations in prostate cancer varies across ethnic populations. A recent study uses RNA-seq to profile the mutational landscape of prostate cancer in a Chinese population to gain additional insights on ethnic variation in this disease.
Cell Research (2012) 22:786-788. doi:10.1038/cr.2012.50; published online 27 March 2012
FULL TEXT | PDF
Browse 1994
